丛集性头痛的诊断、病理生理与治疗
丛集性头痛是三叉自主神经性头痛,以严格单侧、短暂剧烈头痛伴同侧自主神经症状或躁动不安为特征。病理生理涉及下丘脑、三叉血管系统和自主神经系统的同步异常活动。曲普坦类是急性发作最有效药物,抗CGRP单克隆抗体正被研究用于预防治疗。
要点
- 丛集性头痛为严格单侧短暂剧烈头痛,伴同侧自主神经症状或躁动。
- 下丘脑在发作周期启动中起基础作用,发作可能需外周神经系统参与。
- 曲普坦类是急性发作最有效药物,抗CGRP单抗正研究用于预防。
核心结论
- 丛集性头痛涉及下丘脑、三叉血管系统和自主神经系统的同步异常活动。
- 曲普坦类是急性丛集性头痛发作最有效的药物。
- 抗CGRP单克隆抗体正在被研究用于丛集性头痛的预防治疗。
主要发现
- 丛集性头痛以严格单侧、短暂剧烈头痛发作为特征,伴同侧自主神经症状或躁动不安。
- 疾病严重程度对患者生活质量有重大影响,某些情况下可能导致自杀意念。
- 下丘脑似乎在学习允许发作启动的许可状态中起基础作用,而发作可能需外周神经系统参与。
临床怎么用
- 急性发作可使用曲普坦类药物。
- 抗CGRP单克隆抗体可能成为预防治疗选择,但仍处于研究阶段。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cluster headache is a trigeminal autonomic cephalalgia characterised by extremely painful, strictly unilateral, short-lasting headache attacks accompanied by ipsilateral autonomic symptoms or the sense of restlessness and agitation, or both. The severity of the disorder has major effects on the patient's quality of life and, in some cases, might lead to suicidal ideation. Cluster headache is now thought to involve a synchronised abnormal activity in the hypothalamus, the trigeminovascular system, and the autonomic nervous system. The hypothalamus appears to play a fundamental role in the generation of a permissive state that allows the initiation of an episode, whereas the attacks are likely to require the involvement of the peripheral nervous system. Triptans are the most effective drugs to treat an acute cluster headache attack. Monoclonal antibodies against calcitonin gene-related peptide, a crucial neurotransmitter of the trigeminal system, are under investigation for the preventive treatment of cluster headache. These studies will increase our understanding of the disorder and perhaps reveal other therapeutic targets.
引用
- Hoffmann J, May A. Diagnosis, pathophysiology, and management of cluster headache. Lancet Neurol. 2017. PMID: 29174963. doi:10.1016/S1474-4422(17)30405-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。